ALLIANCEBERNSTEIN L.P. - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$5,340,214
+64.3%
52,427
+62.8%
0.00%
+100.0%
Q2 2023$3,250,008
+36.5%
32,207
+24.5%
0.00%0.0%
Q1 2023$2,380,868
-1.9%
25,879
-3.2%
0.00%0.0%
Q4 2022$2,426,579
+20.2%
26,748
+0.7%
0.00%0.0%
Q3 2022$2,019,000
-8.2%
26,567
+2.1%
0.00%0.0%
Q2 2022$2,199,000
-10.9%
26,013
-7.5%
0.00%0.0%
Q1 2022$2,467,000
-2.5%
28,117
-2.8%
0.00%0.0%
Q4 2021$2,529,000
+6.4%
28,917
-0.5%
0.00%0.0%
Q3 2021$2,377,000
-11.1%
29,071
-0.8%
0.00%0.0%
Q2 2021$2,673,000
-57.7%
29,301
-60.3%
0.00%
-66.7%
Q1 2021$6,312,000
+108.6%
73,847
+130.5%
0.00%
+200.0%
Q4 2020$3,026,000
+11.6%
32,042
+2.8%
0.00%0.0%
Q3 2020$2,711,000
+3.9%
31,173
+4.3%
0.00%
-50.0%
Q2 2020$2,609,000
+9.7%
29,877
+3.6%
0.00%0.0%
Q1 2020$2,378,000
-14.9%
28,839
-2.3%
0.00%0.0%
Q4 2019$2,796,000
+10.6%
29,533
+1.5%
0.00%0.0%
Q3 2019$2,529,000
-2.7%
29,105
+2.2%
0.00%0.0%
Q2 2019$2,600,000
-76.2%
28,475
-75.0%
0.00%
-71.4%
Q1 2019$10,929,000
+41.6%
113,680
+26.4%
0.01%
+16.7%
Q4 2018$7,717,000
-46.1%
89,933
-45.9%
0.01%
-33.3%
Q3 2018$14,325,000
+265.2%
166,257
+220.1%
0.01%
+200.0%
Q2 2018$3,923,000
-9.0%
51,939
-2.6%
0.00%0.0%
Q1 2018$4,310,000
-5.8%
53,311
-2.1%
0.00%0.0%
Q4 2017$4,573,000
-25.9%
54,471
-24.3%
0.00%
-40.0%
Q3 2017$6,174,000
+30.9%
71,920
+27.3%
0.01%
+25.0%
Q2 2017$4,716,000
+15.4%
56,504
+2.7%
0.00%
+33.3%
Q1 2017$4,086,000
+37.0%
55,021
+34.4%
0.00%
+50.0%
Q4 2016$2,982,000
-11.5%
40,940
-4.0%
0.00%
-33.3%
Q3 2016$3,368,000
+19.1%
42,653
+24.5%
0.00%
+50.0%
Q2 2016$2,827,000
+32.7%
34,268
+16.5%
0.00%0.0%
Q1 2016$2,131,000
+5.4%
29,424
+25.2%
0.00%0.0%
Q4 2015$2,021,000
-29.5%
23,493
-24.7%
0.00%0.0%
Q3 2015$2,866,000
-36.6%
31,184
-32.2%
0.00%
-50.0%
Q2 2015$4,521,000
+30.0%
45,974
+30.3%
0.00%
+33.3%
Q1 2015$3,479,000
+21.7%
35,280
+14.3%
0.00%
+50.0%
Q4 2014$2,859,000
-1.3%
30,853
+0.2%
0.00%0.0%
Q3 2014$2,898,000
-10.0%
30,787
-13.5%
0.00%
-33.3%
Q2 2014$3,221,000
+5.2%
35,580
-1.2%
0.00%0.0%
Q1 2014$3,061,000
-2.7%
36,005
-8.0%
0.00%0.0%
Q4 2013$3,146,000
+5.7%
39,135
+0.9%
0.00%0.0%
Q3 2013$2,976,000
+29.2%
38,801
+19.1%
0.00%
+50.0%
Q2 2013$2,304,00032,5830.00%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders